Dicerna Pharmaceuticals' Series B Round

Dicerna Pharmaceuticals raised a round of funding on August 19, 2010.

Dicerna Pharmaceuticals is a pharmaceutical company developing RNA interference (RNAi)-based therapeutics against genetically-defined targets in multiple disease areas, including cancer. Dicerna's the…

Articles about Dicerna Pharmaceuticals' Series B Round: